FIELD: pharmacology.
SUBSTANCE: (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide or a pharmaceutically acceptable salt thereof is administered in an effective daily dose. Treatment takes at least 12 weeks.
EFFECT: effective treatment of cognitive impairment in patients with mild to moderate cognitive impairment who have a subnormal value for one or more cognitive assessment tests.
40 cl, 19 tbl, 15 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| TREATING COGNITIVE DISORDERS WITH (R)-7-CHLOR-N-(QUINUCLIDIN-3-YL) BENZO[b] THIOPHEN-2-CARBOXAMIDE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS | 2009 |
|
RU2532327C2 |
| CRYSTALLINE FORM OF (R)-7-CHLORO-N-(QUINUCLIDIN-3-YL)BENZO[b]THIOPHENE-2-CARBOXAMIDE HYDROCHLORIDE MONOHYDRATE | 2011 |
|
RU2577334C2 |
| TREATMENT OF COGNITIVE DISORDERS WITH (R)-7-CHLORO-N-(QUINUCLIDIN-3-YL)BENZO[B]THIOPHENE-2-CARBOXAMIDE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | 2014 |
|
RU2662560C2 |
| APPLICATION OF CARBAMAZEPINE DERIVATIVES FOR TREATING EXCITATION IN PATIENTS SUFFERING FROM DEMENTIA | 2004 |
|
RU2351338C2 |
| METHODS FOR TREATMENT OF DISORDERS OF CIRCADIAN SLEEP RHYTHM | 2017 |
|
RU2763493C2 |
| AGONISTS OF 5-HT4-RECEPTORS FOR TREATING DEMENTIA | 2011 |
|
RU2569733C2 |
| METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTIONS | 2012 |
|
RU2665021C2 |
| METHODS AND COMPOSITIONS TO IMPROVE COGNITIVE FUNCTIONS | 2012 |
|
RU2792010C2 |
| NEW APPROACH TO TREATMENT OF ALZHEIMER'S DISEASE | 1995 |
|
RU2106864C1 |
| USING SIP RECEPTOR MODULATOR | 2008 |
|
RU2498796C2 |
